Literature DB >> 18835072

Ferritin for the clinician.

Mary Ann Knovich1, Jonathan A Storey, Lan G Coffman, Suzy V Torti, Frank M Torti.   

Abstract

Ferritin, a major iron storage protein, is essential to iron homeostasis and is involved in a wide range of physiologic and pathologic processes. In clinical medicine, ferritin is predominantly utilized as a serum marker of total body iron stores. In cases of iron deficiency and overload, serum ferritin serves a critical role in both diagnosis and management. Elevated serum and tissue ferritin are linked to coronary artery disease, malignancy, and poor outcomes following stem cell transplantation. Ferritin is directly implicated in less common but potentially devastating human diseases including sideroblastic anemias, neurodegenerative disorders, and hemophagocytic syndrome. Additionally, recent research describes novel functions of ferritin independent of iron storage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18835072      PMCID: PMC2717717          DOI: 10.1016/j.blre.2008.08.001

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  89 in total

1.  Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload.

Authors:  L J Anderson; S Holden; B Davis; E Prescott; C C Charrier; N H Bunce; D N Firmin; B Wonke; J Porter; J M Walker; D J Pennell
Journal:  Eur Heart J       Date:  2001-12       Impact factor: 29.983

Review 2.  Regulation of ferritin genes and protein.

Authors:  Frank M Torti; Suzy V Torti
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

3.  Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia.

Authors:  Mario Cazzola; Rosangela Invernizzi; Gaetano Bergamaschi; Sonia Levi; Barbara Corsi; Erica Travaglino; Valeria Rolandi; Giorgio Biasiotto; Jim Drysdale; Paolo Arosio
Journal:  Blood       Date:  2002-10-24       Impact factor: 22.113

Review 4.  The role of iron chelation in cancer therapy.

Authors:  Joan L Buss; Frank M Torti; Suzy V Torti
Journal:  Curr Med Chem       Date:  2003-06       Impact factor: 4.530

Review 5.  Hemophagocytosis in autoimmune disease.

Authors:  I Sekigawa; J Suzuki; M Nawata; K Ikeda; M Koike; N Iida; H Hashimoto; K Oshimi
Journal:  Clin Exp Rheumatol       Date:  2001 May-Jun       Impact factor: 4.473

6.  Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes.

Authors:  U Emmenegger; U Frey; A Reimers; C Fux; D Semela; P Cottagnoud; P J Spaeth; K A Neftel
Journal:  Am J Hematol       Date:  2001-09       Impact factor: 10.047

7.  Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome.

Authors:  C J Earley; J R Connor; J L Beard; E A Malecki; D K Epstein; R P Allen
Journal:  Neurology       Date:  2000-04-25       Impact factor: 9.910

8.  Early impairment of myocardial function in young patients with beta-thalassemia major.

Authors:  Damiano Magrì; Susanna Sciomer; Francesco Fedele; Gianfranco Gualdi; Emanuele Casciani; Pellegrina Pugliese; Anna Losardo; Giancarlo Ferrazza; Eleonora Pasquazzi; Erika Schifano; Eleonora Mussino; Raffaele Quaglione; Gianfranco Piccirillo
Journal:  Eur J Haematol       Date:  2008-02-12       Impact factor: 2.997

9.  Ferritin binds to light chain of human H-kininogen and inhibits kallikrein-mediated bradykinin release.

Authors:  Narayanan Parthasarathy; Suzy V Torti; Frank M Torti
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

10.  Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation.

Authors:  A Altès; A F Remacha; A Sureda; R Martino; J Briones; C Canals; S Brunet; J Sierra; E Gimferrer
Journal:  Bone Marrow Transplant       Date:  2002-06       Impact factor: 5.483

View more
  127 in total

Review 1.  Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developments.

Authors:  Heather A Leitch
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

2.  Serum ferritin levels, socio-demographic factors and desferrioxamine therapy in multi-transfused thalassemia major patients at a government tertiary care hospital of Karachi, Pakistan.

Authors:  Haris Riaz; Talha Riaz; Muhammad Ubaid Khan; Sina Aziz; Faizan Ullah; Anis Rehman; Qandeel Zafar; Abdul Nafey Kazi
Journal:  BMC Res Notes       Date:  2011-08-11

3.  The CD68(+)/H-ferritin(+) cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: correlation with disease severity and implication for pathogenesis.

Authors:  P Ruscitti; F Ciccia; P Cipriani; G Guggino; P Di Benedetto; A Rizzo; V Liakouli; O Berardicurti; F Carubbi; G Triolo; R Giacomelli
Journal:  Clin Exp Immunol       Date:  2015-12-08       Impact factor: 4.330

Review 4.  Synthetic and natural iron chelators: therapeutic potential and clinical use.

Authors:  Heather C Hatcher; Ravi N Singh; Frank M Torti; Suzy V Torti
Journal:  Future Med Chem       Date:  2009-12       Impact factor: 3.808

5.  Extremely High Ferritinemia Associated with Haemophagocytic Lympho Histiocytosis (HLH).

Authors:  Neelima Verma; Jyoti Chakraverty; Pankaj Baweja; Alka Girotra; Leena Chatterjee; Manish Chugh
Journal:  Indian J Clin Biochem       Date:  2016-02-17

6.  Anemia in frailty.

Authors:  Cindy N Roy
Journal:  Clin Geriatr Med       Date:  2011-02       Impact factor: 3.076

Review 7.  Anemia of inflammation.

Authors:  Guenter Weiss; Tomas Ganz; Lawrence T Goodnough
Journal:  Blood       Date:  2018-11-06       Impact factor: 22.113

8.  Detergent Insoluble Proteins and Inclusion Body-Like Structures Immunoreactive for PRKDC/DNA-PK/DNA-PKcs, FTL, NNT, and AIFM1 in the Amygdala of Cognitively Impaired Elderly Persons.

Authors:  Jozsef Gal; Jing Chen; Yuriko Katsumata; David W Fardo; Wang-Xia Wang; Sergey Artiushin; Douglas Price; Sonya Anderson; Ela Patel; Haining Zhu; Peter T Nelson
Journal:  J Neuropathol Exp Neurol       Date:  2018-01-01       Impact factor: 3.685

9.  Yield of screening for long-term complications using the children's oncology group long-term follow-up guidelines.

Authors:  Wendy Landier; Saro H Armenian; Jin Lee; Ola Thomas; F Lennie Wong; Liton Francisco; Claudia Herrera; Clare Kasper; Karla D Wilson; Meghan Zomorodi; Smita Bhatia
Journal:  J Clin Oncol       Date:  2012-10-22       Impact factor: 44.544

10.  The transplant iron score as a predictor of stem cell transplant survival.

Authors:  Jonathan A Storey; Rebecca F Connor; Zachary T Lewis; David Hurd; Gregory Pomper; Yi K Keung; Manisha Grover; James Lovato; Suzy V Torti; Frank M Torti; István Molnár
Journal:  J Hematol Oncol       Date:  2009-10-24       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.